摘要
新辅助治疗作为胃癌综合治疗中的重要一环,目前已被各大指南所推荐。局部进展期的胃癌患者在经过新辅助治疗后,部分可以达到病理完全缓解,从而得到相对较好的预后。CEA、CA-199等肿瘤标志物在胃癌诊断方面有重要意义,但在新辅助治疗方面研究较少,本文通过对胃癌新辅助治疗相关文献进行学习,探讨胃癌新辅助治疗前后肿瘤标志物变化与其治疗疗效关系。Neoadjuvant therapy, as an important part of comprehensive treatment for gastric cancer, has been recommended by various guidelines. After neoadjuvant therapy, some patients with locally advanced gastric cancer can achieve complete pathological remission, thereby achieving relatively good prognosis. Tumor markers such as CEA and CA-199 are of great significance in the diagnosis of gastric cancer, but there is limited research on neoadjuvant therapy. This article aims to study relevant literature on neoadjuvant therapy for gastric cancer and discuss the relationship between changes in tumor markers before and after neoadjuvant therapy and its therapeutic efficacy.
出处
《临床医学进展》
2024年第9期402-406,共5页
Advances in Clinical Medicine
